Adam Mostafa

Adam S.
Mostafa currently works at Cumberland Pharmaceuticals, Inc., as Managing Director, Precision Biologics, Inc., as Director, and Satellos Bioscience, Inc., as Director from 2021.
Mr. Mostafa also formerly worked at Cantor Fitzgerald & Co., as Managing Director from 2015 to 2016, AQR Capital Management LLC, as Associate from 2003 to 2007, Arsanis, Inc., as Chief Financial Officer & Treasurer, X4 Pharmaceuticals, Inc., as Chief Financial Officer, CRT Capital Group LLC, as Vice President-Investment Banking Group from 2007 to 2011, Salomon Smith Barney International Ltd., as Analyst, Abpro Corp., as Chief Financial Officer from 2016 to 2018, and X4 Pharmaceuticals, Inc., as Chief Financial Officer, Co-Secretary & Treasurer from 2022 to 2025.
Mr. Mostafa received his undergraduate degree in 2001 from Brown University.